Ident. | Authors (with country if any) | Title |
---|
000654 (2015) |
C. Fidalgo [Italie] ; W K D. Ko [Royaume-Uni] ; E. Tronci [Italie] ; Q. Li [République populaire de Chine] ; R. Stancampiano [Italie] ; Q. Chuan [République populaire de Chine] ; E. Bezard [République populaire de Chine] ; M. Carta [Italie] | Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease. |
001514 (2011-12-15) |
M. Carta [Italie] ; E. Bezard [France] | Contribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesia. |
001538 (2011-08) |
G. Charron [France] ; E. Doudnikoff [France] ; A. Laux [France] ; A. Berthet [France] ; G. Porras [France] ; M.-H. Canron [France] ; P. Barroso-Chinea [France] ; Q. Li [Royaume-Uni] ; C. Qin [France] ; M. Nosten-Bertrand [France] ; B. Giros [France] ; F. Delalande [France] ; A. Van Dorsselaer [France] ; A. Vital [France] ; Y. Goumon [France] ; E. Bezard [France] | Endogenous morphine-like compound immunoreactivity increases in parkinsonism |
001950 (2011) |
M. Carta [Suède, Italie] ; E. Bezard [France] | CONTRIBUTION OF PRE-SYNAPTIC MECHANISMS TO L-DOPA-INDUCED DYSKINESIA |
002755 (2008) |
E. Y. Pioli [France] ; W. Meissner [France] ; R. Sohr [Allemagne] ; C. E. Gross [France] ; E. Bezard [France] ; B. H. Bioulac [France] | DIFFERENTIAL BEHAVIORAL EFFECTS OF PARTIAL BILATERAL LESIONS OF VENTRAL TEGMENTAL AREA OR SUBSTANTIA NIGRA PARS COMPACTA IN RATS |
002F36 (2005) |
E. Bezard [France] ; C E Gross ; Li Qin ; V V Gurevich ; J L Benovic ; E V Gurevich | L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. |
003081 (2005) |
I. Ghorayeb [France] ; E. Bezard [France] ; P. O. Fernagut [France] ; B. Bioulac [France] ; F. Tison [France] | Modèles animaux des syndromes parkinsoniens |
003B26 (2001) |
E. Bezard [France] ; J M Brotchie ; C E Gross | Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. |
003D94 (2001) |
E. Bezard [Royaume-Uni] ; T. Boraud [France] ; S. Chalon [France] ; J. M. Brotchie [Royaume-Uni] ; D. Guilloteau [France] ; C. E. Gross [France] | Pallidal border cells : An anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey |
003E72 (2000) |
I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. Tison | Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. |
003F16 (2000) |
T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E Gross | Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey. |
003F36 (2000) |
E. Bezard [France] ; M. Jaber ; F. Gonon ; A. Boireau ; B. Bloch ; C E Gross | Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse. |
004095 (2000) |
Th Boraud [France] ; E. Bezard [France] ; J. M Stutzmann [France] ; B. Bioulac [France] ; C. E Gross [France] | Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey |
004258 (2000) |
T. Boraud [France] ; E. Bezard [France] ; J. M. Stutzmann [France] ; B. Bioulac [France] ; C. E. Gross [France] | Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey |
004270 (2000) |
C. Imbert [France] ; E. Bezard [France] ; S. Guitraud [France] ; T. Boraud [France] ; C. E. Gross [France] | Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey |
004307 (1999) |
D. Guehl [France] ; E. Bezard ; S. Dovero ; T. Boraud ; B. Bioulac ; C. Gross | Trichloroethylene and parkinsonism: a human and experimental observation. |
004346 (1999) |
E. Bezard [France] ; T. Boraud ; B. Bioulac ; C E Gross | Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. |
004351 (1999) |
C E Gross [France] ; T. Boraud ; D. Guehl ; B. Bioulac ; E. Bezard | From experimentation to the surgical treatment of Parkinson's disease: prelude or suite in basal ganglia research? |
004356 (1999) |
E. Bezard [France] ; C. Brefel ; F. Tison ; H. Peyro-Saint-Paul ; P. Ladure ; O. Rascol ; C E Gross | Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey. |
004659 (1999) |
E. Bezard [France] ; C. Brefel [France] ; F. Tison [France] ; H. Peyro-Saint-Paul [France] ; P. Ladure [France] ; O. Rascol [France] ; C. E. Gross [France] | Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in mptp-treated monkey |
004682 (1999) |
E. Bezard [France] ; C. E. Gross [France] ; M.-C. Fournier [France] ; S. Dovero [France] ; B. Bloch [France] ; M. Jaber [France] | Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter |